Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
MEDNIK syndrome, previously known as Erythrokeratodermia Variabilis type 3 (EKV3), is characterized by intellectual deficit, enteropathy, sensorineural hearing loss, peripheral neuropathy, lamellar and erythrodermic ichthyosis, and keratodermia (MEDNIK stands for Mental retardation, Enteropathy, Deafness, peripheral Neuropathy, Ichtyosis, Keratodermia).
Features include always present findings: Diarrhea, Increased circulating very long-chain fatty acid concentration, and High forehead; and very common findings: Global developmental delay, Low muscle tone (hypotonia), Dry, scaly skin (ichthyosis), and Inner ear hearing loss (sensorineural hearing impairment) and others. 24 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 6 | Diarrhea, Cholestasis, Liver scarring (fibrosis) (hepatic fibrosis) |
Brain and nerves | 3 | Global developmental delay, Peripheral neuropathy, Intellectual disability |
Skin | 3 | Erythema, Dry, scaly skin (ichthyosis), Thickened, rough skin (hyperkeratosis) |
Muscles | 1 | Low muscle tone (hypotonia) |
Lab test results | 1 | Increased circulating very long-chain fatty acid concentration |
Eyes | 1 | Cataract |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Growth and development | 1 | Growth delay |
Age of onset: at birth.
IDEDNIK syndrome is characterized by enteropathy, growth deficiency, skin manifestations (ichthyosis, erythroderma, and keratoderma), sparse hair, global developmental delay, mild-to-severe intellectual disability, and deafness. Additional manifestations can include liver disease, recurrent infections, and hematologic and ocular manifestations. To date, 24 individuals have been diagnosed with IDEDNIK syndrome – ten individuals with AP1B1-related IDEDNIK syndrome [, , , , , , ] and 14 individuals with AP1S1-related IDEDNIK syndrome [, , , , , ]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. IDEDNIK Syndrome: Frequency of Select Features Feature | Proportion of Persons w/Feature1 AP1B1-related IDEDNIK syndrome(n=10) | AP1S1-related IDEDNIK syndrome(n=14) GI manifestations/ poor growth
Infantile-onset diarrhea | 3/3 | 14/14 |
|---|---|---|
Poor weight gain | 8/8 | 5/5 |
AP1S1 encodes adaptor related protein complex 1 subunit sigma 1 (158 aa). Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. Highest expression in Cells Cultured fibroblasts (130.4 TPM) and Brain Frontal Cortex BA9 (125.7 TPM).
MEDNIK syndrome is caused by mutations in the AP1S1 gene on chromosome 7.
AP1S1 is classified as a druggable target (Transporter category) with score 0.0.
No consensus clinical diagnostic criteria for IDEDNIK syndrome have been published.
IDEDNIK syndrome should be suspected in probands with the following clinical, laboratory, histopathology, and imaging findings and family history.
Clinical findings
Infantile-onset diarrhea
Poor weight gain and growth deficiency
Skin and hair manifestations: ichthyosis, erythroderma, hyperkeratosis, sparse hair, and alopecia
Global developmental delay
Hypotonia
Sensorineural hearing loss
Intellectual disability (mild to severe)
Hepatomegaly
Recurrent infections
Ocular manifestations: photophobia, corneal scarring, and keratitis
Characteristic facial features: high anterior hairline, frontal bossing, low-set ears, and depressed nasal bridge
Laboratory findings
Source: GeneReviews — "IDEDNIK Syndrome"
IDEDNIK syndrome presents a combination of clinical and biochemical signs overlapping several disorders, including Menkes disease and Wilson disease . Table 3. Genes of Interest in the Differential Diagnosis of IDEDNIK Syndrome
Gene | Disorder | MOI | Features of Disorder |
|---|---|---|---|
ATP7A | Menkes disease (See ATP7A-Related Copper Transport Disorders.) | XL | Low serum copper ceruloplasmin concentrations; growth deficiency, sparse hair, hypotonia, ID, seizures |
Wilson disease |
Genetic testing for AP1S1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for MEDNIK syndrome has been reported in the published literature.
No approved treatments are currently available for MEDNIK syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for IDEDNIK syndrome have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with IDEDNIK syndrome, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 4.
IDEDNIK Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Consultation w/metabolic physician/ biochemical geneticist |
| • Consultation w/ gastroenterologist dietitian
Assessment for aspiration risk
| May require dietary modifications, supplementation, tube feeding, or parenteral nutrition
| Dermatology consultation |
| Developmental assessment | • To incl motor, adaptive, cognitive, speech-language eval
Eval for early intervention/ special education
| Orthopedics/ physical medicine rehab/ PT OT eval | To incl assessment of:
Gross motor fine motor skills
Mobility, ADL, need for adaptive devices
Need for PT (to improve gross motor skills) /or OT (to improve fine motor skills)
| Audiologic eval for sensorineural hearing loss |
| Neurologic eval | • To incl brain MRI
Consider EEG if seizures are a concern.
Assess for peripheral neuropathy esp in older persons.
Neurobehavioral/
Source: GeneReviews — "IDEDNIK Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "IDEDNIK Syndrome"
View trials for MEDNIK syndrome
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. IDEDNIK Syndrome: Recommended Surveillance
System/Concern | Evaluation | Frequency |
|---|---|---|
Audiology | Audiologic eval for sensorineural hearing loss | Frequency per audiologist Neurologic |
Recurrent infections/ Respiratory | Monitor for evidence of aspiration, respiratory infections. | At each visit Hematologic |
Ophthalmologic involvement | Assess for keratitis, cataract, accommodative esotropia. | Frequency per ophthalmologist Endocrine |
Source: GeneReviews — "IDEDNIK Syndrome"
Phenotype severity distribution: 3 always present features, 8 very common features, 8 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for MEDNIK syndrome.
7 publications have been identified in PubMed for MEDNIK syndrome. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Diagnostic / Biomarker (17%).
Sidorina A (2026). [PMID: 41429203](https://pubmed.ncbi.nlm.nih.gov/41429203/). *Journal of lipid research*. [Diagnostic / Biomarker]
Antos A (2026). [PMID: 42122051](https://pubmed.ncbi.nlm.nih.gov/42122051/). *Diagnostics (Basel)*. [Review / Meta-Analysis]
Duan L (2025). [PMID: 40901618](https://pubmed.ncbi.nlm.nih.gov/40901618/). *International journal of genomics*. [Case Report / Case Series]
Cavalli A (2025). [PMID: 41517358](https://pubmed.ncbi.nlm.nih.gov/41517358/). *Journal of clinical medicine*. [Case Report / Case Series]
Wu R (2025). [PMID: 41404470](https://pubmed.ncbi.nlm.nih.gov/41404470/). *Frontiers in neurology*. [Review / Meta-Analysis]
Rackova M (2024). [PMID: 39269494](https://pubmed.ncbi.nlm.nih.gov/39269494/). *Journal of molecular medicine (Berlin, Germany)*. [Basic Science / Preclinical]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 12:30 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about MEDNIK syndrome
Growth deficiency
8/8 |
7/7 |
Skin hair manifestations | Ichthyosis | 10/10 |
Erythroderma | 9/10 | 6/7 |
Hyperkeratosis | 8/10 | 6/7 |
Sparse hair | 8/10 | 1/1 |
Alopecia | 4/7 | NR |
Development/ neurologic manifestations | Global developmental delay | 10/10 |
Hypotonia | 2/2 | 6/6 |
Sensorineural hearing loss | 10/10 | 8/8 |
Intellectual disability | 4/9 | 8/8 |
Peripheral neuropathy | NR | 3/6 |
Seizures | 1/1 | 2/2 |
Cerebral atrophy | 2/5 | 6/6 |
Basal ganglia abnormalities | NR | 3/6 |
Thin corpus callosum | 3/5 | NR |
Liver manifestations | Hepatopathy2 | 3/4 |
Hepatomegaly | 2/3 | 1/1 |
Elevated transaminases | 4/6 | 8/8 |
Elevated total bile acid levels | 1/2 | 4/4 |
Immune system/ hematologic manifestations | Recurrent infections | 6/6 |
Anemia | 2/4 | 1/1 |
Thrombocytopenia | 3/6 | 1/1 |
Ocular manifestations | Photophobia | 6/7 |
Corneal scarring | 3/5 | NR |
Keratitis | 2/4 | NR |
Laboratory findings | Reduced ceruloplasmin | 6/8 |
Reduced total serum copper | 6/8 | 6/6 NR = not reported Because limited clinical details are available for some reported individuals included in this table, the denominator represents the total number of individuals in whom the corresponding finding was reported. 2. Enteropathy. |
Source: GeneReviews — "IDEDNIK Syndrome"
Low serum ceruloplasmin concentration, high liver copper concentration; hepatomegaly, hepatic cirrhosis, anemia |
Kayser-Fleischer rings, renal tubular dysfunction, osteoporosis, tremor, dementia, drooling CP |
Aceruloplasminemia | AR | serum copper, serum ceruloplasmin | Iron deposition in liver, pancreas, basal ganglia, thalamus, cerebellum; diabetes mellitus SLC33A1 |
Huppke-Brendel syndrome | AR | serum copper, serum ceruloplasmin; hearing loss, sparse hair, hypotonia, ID | Lack of GI manifestations assoc w/IDEDNIK syndrome |
SNAP29 | CEDNIK (cerebral dysgenesis, neuropathy, ichthyosis, palmoplantar keratoderma) syndrome (OMIM 609528) | AR | Ichthyosis, keratoderma, poor growth, sensorineural hearing loss, peripheral neuropathy, DD/ID |
Source: GeneReviews — "IDEDNIK Syndrome"